Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP. / Ranjbar, Hoda; Soti, Monavareh; Kohlmeier, Kristi A; Janahmadi, Mahyar; Shabani, Mohammad.

In: BMC Neuroscience, Vol. 24, No. 1, 18, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Ranjbar, H, Soti, M, Kohlmeier, KA, Janahmadi, M & Shabani, M 2023, 'Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP', BMC Neuroscience, vol. 24, no. 1, 18. https://doi.org/10.1186/s12868-023-00786-4

APA

Ranjbar, H., Soti, M., Kohlmeier, K. A., Janahmadi, M., & Shabani, M. (2023). Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP. BMC Neuroscience, 24(1), [18]. https://doi.org/10.1186/s12868-023-00786-4

Vancouver

Ranjbar H, Soti M, Kohlmeier KA, Janahmadi M, Shabani M. Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP. BMC Neuroscience. 2023;24(1). 18. https://doi.org/10.1186/s12868-023-00786-4

Author

Ranjbar, Hoda ; Soti, Monavareh ; Kohlmeier, Kristi A ; Janahmadi, Mahyar ; Shabani, Mohammad. / Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP. In: BMC Neuroscience. 2023 ; Vol. 24, No. 1.

Bibtex

@article{9f1096a43b0d4fa08421990cadb8b8cf,
title = "Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP",
abstract = "INTRODUCTION: Although ataxia is associated with cerebellar dysfunction, little is known about the effects of 3-AP exposure on Purkinje cell electrophysiological properties. Here, we evaluated these parameters in cerebellar vermis brain slices.METHODS: Purkinje cells were exposed to artificial cerebrospinal fluid (aCSF) (control) or to 1 mM 3-acetylpyridine (3-AP) in the recording chamber. The effects of a cannabinoid agonist (WIN; 7.5 nmol) and a cannabinoid antagonist (AM; 20 nmol) were evaluated under both conditions.RESULTS: Exposure to 3-AP induced dramatic changes in cellular excitability that likely would affect Purkinje cell output. In whole-cell current clamp recordings, 3-AP-exposed Purkinje cells demonstrated a significantly higher frequency of action potentials, a larger afterhyperpolarization (AHP), and a larger rebound of action potentials. In addition, 3-AP caused a significant decrease in the interspike interval (ISI), half-width, and first spike latency. Remarkably, the action potential frequency, AHP amplitude, rebound, ISI, action potential halfwidth, and first spike latency were no longer different from controls in 3-AP cells treated with AM. Sag percentage, on the other hand, showed no significant difference under any treatment condition, indicating that cannabinoids' actions on 3-AP-mediated Purkinje cell changes may not include effects on neuronal excitability through changes of Ih.CONCLUSIONS: These data show that cannabinoid antagonists reduce the excitability of Purkinje cells following exposure to 3-AP and suggest their potential as therapeutics in cerebellar dysfunctions.",
keywords = "Purkinje Cells, Action Potentials, Brain, Cannabinoid Receptor Antagonists, Patch-Clamp Techniques, Receptor, Cannabinoid, CB1",
author = "Hoda Ranjbar and Monavareh Soti and Kohlmeier, {Kristi A} and Mahyar Janahmadi and Mohammad Shabani",
note = "{\textcopyright} 2023. The Author(s).",
year = "2023",
doi = "10.1186/s12868-023-00786-4",
language = "English",
volume = "24",
journal = "B M C Neuroscience",
issn = "1471-2202",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Pharmacologic antagonism of CB1 receptors improves electrophysiological alterations in Purkinje cells exposed to 3-AP

AU - Ranjbar, Hoda

AU - Soti, Monavareh

AU - Kohlmeier, Kristi A

AU - Janahmadi, Mahyar

AU - Shabani, Mohammad

N1 - © 2023. The Author(s).

PY - 2023

Y1 - 2023

N2 - INTRODUCTION: Although ataxia is associated with cerebellar dysfunction, little is known about the effects of 3-AP exposure on Purkinje cell electrophysiological properties. Here, we evaluated these parameters in cerebellar vermis brain slices.METHODS: Purkinje cells were exposed to artificial cerebrospinal fluid (aCSF) (control) or to 1 mM 3-acetylpyridine (3-AP) in the recording chamber. The effects of a cannabinoid agonist (WIN; 7.5 nmol) and a cannabinoid antagonist (AM; 20 nmol) were evaluated under both conditions.RESULTS: Exposure to 3-AP induced dramatic changes in cellular excitability that likely would affect Purkinje cell output. In whole-cell current clamp recordings, 3-AP-exposed Purkinje cells demonstrated a significantly higher frequency of action potentials, a larger afterhyperpolarization (AHP), and a larger rebound of action potentials. In addition, 3-AP caused a significant decrease in the interspike interval (ISI), half-width, and first spike latency. Remarkably, the action potential frequency, AHP amplitude, rebound, ISI, action potential halfwidth, and first spike latency were no longer different from controls in 3-AP cells treated with AM. Sag percentage, on the other hand, showed no significant difference under any treatment condition, indicating that cannabinoids' actions on 3-AP-mediated Purkinje cell changes may not include effects on neuronal excitability through changes of Ih.CONCLUSIONS: These data show that cannabinoid antagonists reduce the excitability of Purkinje cells following exposure to 3-AP and suggest their potential as therapeutics in cerebellar dysfunctions.

AB - INTRODUCTION: Although ataxia is associated with cerebellar dysfunction, little is known about the effects of 3-AP exposure on Purkinje cell electrophysiological properties. Here, we evaluated these parameters in cerebellar vermis brain slices.METHODS: Purkinje cells were exposed to artificial cerebrospinal fluid (aCSF) (control) or to 1 mM 3-acetylpyridine (3-AP) in the recording chamber. The effects of a cannabinoid agonist (WIN; 7.5 nmol) and a cannabinoid antagonist (AM; 20 nmol) were evaluated under both conditions.RESULTS: Exposure to 3-AP induced dramatic changes in cellular excitability that likely would affect Purkinje cell output. In whole-cell current clamp recordings, 3-AP-exposed Purkinje cells demonstrated a significantly higher frequency of action potentials, a larger afterhyperpolarization (AHP), and a larger rebound of action potentials. In addition, 3-AP caused a significant decrease in the interspike interval (ISI), half-width, and first spike latency. Remarkably, the action potential frequency, AHP amplitude, rebound, ISI, action potential halfwidth, and first spike latency were no longer different from controls in 3-AP cells treated with AM. Sag percentage, on the other hand, showed no significant difference under any treatment condition, indicating that cannabinoids' actions on 3-AP-mediated Purkinje cell changes may not include effects on neuronal excitability through changes of Ih.CONCLUSIONS: These data show that cannabinoid antagonists reduce the excitability of Purkinje cells following exposure to 3-AP and suggest their potential as therapeutics in cerebellar dysfunctions.

KW - Purkinje Cells

KW - Action Potentials

KW - Brain

KW - Cannabinoid Receptor Antagonists

KW - Patch-Clamp Techniques

KW - Receptor, Cannabinoid, CB1

U2 - 10.1186/s12868-023-00786-4

DO - 10.1186/s12868-023-00786-4

M3 - Journal article

C2 - 36869289

VL - 24

JO - B M C Neuroscience

JF - B M C Neuroscience

SN - 1471-2202

IS - 1

M1 - 18

ER -

ID: 339613262